GILEAD SCIENCES, INC. (GILD) FY2024 YTD Q3 P&L / Income Statement

2024-01-01 to 2024-09-30

Swipe to see the full flow
GILEAD SCIENCES, INC. (GILD) FY2024 YTD Q3 P&L / Income StatementIncome statement for 2024-01-01 through 2024-09-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUE RECONCILIATIONREVENUEGROSSOPERATINGPRE-TAXNETUNITED STATESEuropeRest of WorldTotal revenuesRevenue before reconciliation (calculated)Components above reported revenue (calculated)Gross profit (calculated)Cost of goods soldOperating income (loss)Operating expenses (calculated)Income (loss) before income taxesOther income (expense), net (calculated)Net income (loss)Income tax (benefit) expenseRevenue before reconciliation (calculated)Revenue beforereconciliation(calculated)$21.19 BGross profit (calculated)Gross profit(calculated)$16.52 BOperating income (loss)Operatingincome (loss)−$790.00 MIncome (loss) before income taxesIncome (loss)before income taxes−$1.48 BTotal revenuesTotal revenues$21.19 BNet income (loss)Net income (loss)−$1.30 BOperating expenses (calculated)Operating expenses(calculated)$17.31 BIncome tax (benefit) expenseIncome tax(benefit) expense−$174.00 MUNITED STATESUNITED STATES$15.02 BEuropeEurope$3.46 BCost of goods soldCost of goods sold$4.67 BRest of WorldRest of World$2.70 BComponents above reported revenue (calculated)Components abovereported revenue(calculated)−$1.00 MOther income (expense), net (calculated)Other income,net (calculated)−$687.00 M
Chart details

GILEAD SCIENCES, INC. (GILD) FY2024 YTD Q3 P&L / Income Statement

Income statement for 2024-01-01 through 2024-09-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues
21,185,000,000 US dollars
Cost of goods sold
4,670,000,000 US dollars
Gross profit (calculated)
16,515,000,000 US dollars
Operating expenses (calculated)
17,305,000,000 US dollars
Operating income (loss)
negative 790,000,000 US dollars
Other income (expense), net (calculated)
negative 687,000,000 US dollars
Income (loss) before income taxes
negative 1,477,000,000 US dollars
Income tax (benefit) expense
negative 174,000,000 US dollars
Net income (loss)
negative 1,303,000,000 US dollars
UNITED STATES
15,024,000,000 US dollars
Europe
3,459,000,000 US dollars
Rest of World
2,703,000,000 US dollars
Selling, general and administrative expenses
4,184,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Acquired in-process research and development expenses
4,674,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Research and development expenses
4,266,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
In-process research and development impairment
4,180,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Revenue before reconciliation (calculated)
21,186,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
Components above reported revenue (calculated)
negative 1,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
GILEAD SCIENCES, INC. (GILD) FY2024 YTD Q3 Revenue by Geography Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

78.0%

Gross profit / revenue

Operating margin

−3.7%

Operating profit / revenue

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!